Healthcare

● The "eases back" framing reflects ordinary price action rather than a confirmed catalyst; no single verified event explains a specific move, and that should be stated plainly.

Few small-cap drugmakers have pursued as unconventional a path as ScilexHolding Company(NASDAQ: SCLX). The specialty-pharmaceutical firm sells a portfolio of non-opioid pain products, yet its recent headlines have been dominated by a proposed nine-figure equity investment and an eye-catching foray into crypto tokens. Against …

Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) is one of the smallest names on theNasdaqbiotech board, and its story in 2026 has been about reinvention rather than a single blockbuster readout. The shares ticked modestly higher in the latest session, but the more relevant narrative is strategic: …

● At a quote measured in tenths of a cent, percentage swings are dominated by market microstructure, a handful of trades can produce enormous percentage moves.

Few consumer-health brands rose and fell as sharply as SmileDirectClub (OTC:SDCCQ). Once a heavily marketed teledentistry disruptor that shipped clear aligners directly to consumers, the company, now quoted as SDCCQ, collapsed into bankruptcy and shut down its global operations.

● Seer is a life-sciences technology company whose Proteograph Product Suite is designed to enable large-scale, deep proteomic analysis, helping researchers study proteins across large sample sets.

Once a prominent name in genomic medicine, Sangamo Therapeutics, Inc (OTC: SGMOQ) is now a company in wind-down, and its stock reflects it. Trading around 16 cents on the over-the-counter market and carrying the 'Q' suffix that signals bankruptcy proceedings, the shares are no …